2 ms·
>Kill the profit motive and you'll kill (most, not all) of the innovative new drugs. Of course not. The alternative is to make the research a public-supported
by bluthru 12y ago
>Kill the profit motive and you'll kill (most, not all) of the innovative new drugs.
Of course not. The alternative is to make the research a public-supported effort. We can hire more scientists with the same amount of money since it isn't being lost to executives or shareholders. Second, all of their information would be open source, which would accelerate advances. Third, drugs don't have to be prioritized by what makes sense from a monetary standpoint and instead can be prioritized from a health standpoint.
- res0nat0r 12y agoYou are not going to get anywhere near the amount of money invested in research if you go with a public supported funding model.
- refurb 12y agoAgreed. The total NIH budget is $31B. Much of which goes to basic research, not drug development. The total spend by pharma and biotech? The best number I could find is from PhRMA (a group of the largest pharma companies, but not all of them) and they spend $49B.